Rexulti 1 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FE839
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,750
Award facts
- Contract value 100% obligated
- $11,749.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,749.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of Rexulti 1 mg tablets (30-count units). This competitively awarded, non-set-aside contract is scheduled for completion by January 16, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. This comprehensive pharmaceutical prime vendor vehicle enables the contractor to supply a broad range of medications, medical devices, vaccines, and specialized healthcare commodities to support military healthcare programs globally, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The prime vendor arrangement demonstrates the contractor's capability to meet federal procurement requirements and efficiently fulfill government demands for essential pharmaceutical products required across military treatment facilities and veterans' healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FE839?
SPE2DR26FE839 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FE839 worth?
The government has obligated $11,750 on SPE2DR26FE839.
Is contract SPE2DR26FE839 an order under another contract?
Yes. SPE2DR26FE839 is a delivery order under SPE2DR25D1103, an indefinite delivery contract.
Was contract SPE2DR26FE839 competed?
The extent of competition for SPE2DR26FE839 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award